Log in to search using one of your social media accounts:


Correspondence Consequence of prioritising pathogens for global antibiotic research

We agree with The Lancet Infectious Diseases that any prioritisation exercise to select important organisms for new antibiotic research inevitably leads to a decrease in emphasis for other pathogens omitted from the selection, such as mycobacteria.1 Restricting the list to promote research on antibacterial agents might be justifiable; however, Mycobacterium tuberculosis is a bacterium. It is insufficient to state that drug resistant tuberculosis “is already a globally established priority for which innovative new treatments are urgently needed”.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Correspondence Source Type: research

Related Links:

More News: Infectious Diseases | Sports Medicine | Tuberculosis